20537 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having three or more nucleosides or nucleotides Double-stranded nucleic acids or oligonucleotides
Genetic amplification of IQGAP1 in cancer
#3902Methods for increasing susceptibility to apoptosis by administering an inhibitor of kallikrein 6 polypeptide activity
#3903METHOD FOR TREATING AND PREVENTING TYPE 2 DIABETES
#3904CONTROL OF PATHOGENS AND PARASITES
#3905Lipid-polymer hybrid particles
#3906Methods and compositions for RNAi mediated inhibition of gene expression in mammals
#3907Inhibitors of branched-chain-aminotransferase-1 (BCAT1) for the treatment of brain tumors
#3908Oligonucleotide chelate complex methods
#3909METHOD FOR TREATING NON-SMALL CELL LUNG CANCER
#3910Antagonists of GRASP55 for use as a medicament
#3911Methods and compositions combining immunotherapy with monocyte activation
#3912Methods and compositions for the specific inhibition of HIF-1α by double-stranded RNA
#3913Treatment of cancer by inhibition of IGFBPs and clusterin
#3914Non-liposomal systems for nucleic acid delivery
#3915Oligonucleotide compositions with enhanced efficiency
#3916Therapeutic applications of P53 isoforms in regenerative medicine, aging and cancer
#3917Bi-functional short-hairpin RNA (bi-shRNA) specific for single-nucleotide mutations
#3918Vivo Delivery of Double Stranded RNA to an Interleukin-12 Producing Organ or Tissue
#3919Oligonucleotide chelate complexes
#3920Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions
#3921Targeting metabolic enzymes in human cancer
#3922COMPOSITIONS AND METHODS FOR TREATING ALPHAVIRUS INFECTION
#3923PVRL4 (Nectin4) is a receptor for measles virus
#3924METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH HYPERACTIVE IMMUNE SYSTEM
#3925Compositions for conferring tolerance to viral disease in social insects, and the use thereof
#3926Synthetic lethality in cancer
#3927Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL
#3928COMPOSITIONS AND METHODS TO BLOCK MTB-MEDIATED EVASION
#3929MODULATION OF HISTONE H2B MONOUBIQUITINATION AND TREATMENT OF CANCER
#3930FSH AND FSH RECEPTOR MODULATOR COMPOSITIONS AND METHODS FOR INHIBITING OSTEOCLASTIC BONE RESORPTION AND BONE LOSS IN OSTEOPOROSIS
#3931Chondrocyte-like cell, and method for producing same
#3932siRNA FOR INHIBITION OF Hif1alpha EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME
#3933Compositions and methods for inhibiting expression of the ALAS1 gene
#3934MicroRNA target site for cell- or tissue-specific inhibition of expression of a transgene
#3935Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
#3936Methods and compositions for RNAi-based cancer treatment
#3937PROGNOSTIC, DIAGNOSTIC, AND CANCER THERAPEUTIC USES OF FANCI AND FANCI MODULATING AGENTS
#3938Method for inhibiting metastasis by using anti-CCL3 antibodies
#3939Modulation of factor 11 expression
#3940Nanoparticles of cerium and amino acids
#3941Nanotechnology approach for inhalation therapies
#3942METHODS FOR TREATING TRIPLE NEGATIVE BREAST CANCER USING BIFUNCTIONAL SRC 3 shRNA
#3943Agents, compositions, and methods for treating pruritus and related skin conditions
#3944Nucleic acids targeting TCTP for use in the treatment of chemo- or hormone-resistant cancers
#3945Compositions and methods for treatment of drug resistant multiple myeloma
#3946METHODS OF TREATING CANCER
#3947Micro-RNA family that modulates fibrosis and uses thereof
#3948Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG
#3949METHODS AND COMPOSITIONS TO TREAT CANCER USING BIFUNCTIONAL SRC 3 shRNA
#3950Micro-RNA family that modulates fibrosis and uses thereof
#3951Polyamine derivatives
#3952Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia
#3953MIR-200 family induces mesenchymal-to-epithelial transition (MET) in ovarian cancer cells
#3954Nanoparticles, nanoparticle delivery methods, and systems of delivery
#3955RNA INTERFERENCE FOR THE TREATMENT OF HEART FAILURE
#3956Delivery of dsRNA to arthropods
#3957CANCER THERAPY USING Bcl-XL-SPECIFIC siNA
#3958Nanotopography-mediated reverse uptake platform for nucleic acid delivery and applications thereof
#3959Pharmaceutical composition including an HIF-2 alpha inhibitor as an active ingredient for preventing or treating arthritis
#3960USE OF LEUKOTRIENE B4 IN COMBINATION WITH A TOLL-LIKE RECEPTOR LIGAND, A RIG-I-LIKE RECEPTOR LIGAND, OR A NOD-LIKE RECEPTOR LIGAND TO ENHANCE THE INNATE IMMUNE RESPONSE
#3961TRANSGLUTAMINASE 2 INHIBITORS FOR USE IN THE PREVENTION OR TREATMENT OF RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS
#3962Methods for promoting reinnervation of auditory hair cells
#3963Genetic inhibition by double-stranded RNA
#3964COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS
#3965Piggy-back delivery of nucleic acids into organisms
#3966DIAGNOSIS AND TREATMENT OF BRAIN TUMORS
#3967Lipid delivery formulations
#3968Inhibitors of SP140 and their use in therapy
#3969SiRNA targeting ETS1 and ELK1 and method of using same in the inhibition of CIP2A gene in cancer treatment
#3970Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic application
#3971SiRNA compositions and methods for potently inhibiting viral infection
#3972Method of treating chronic obstructive pulmonary disease
#3973Inhibition of tat activating regulatory DNA-binding protein 43
#3974COMBINATORIAL METHODS AND COMPOSITIONS FOR TREATMENT OF MELANOMA
#3975Polynucleotides for reducing respiratory syncytial virus gene expression
#3976Cell growth inhibitor and screening method thereof
#3977Breast cancer therapeutics
#3978Application of highly conserved domain sequences from viral genome as template to design therapeutic sliRNAs
#3979Method of Treatment
#3980Cancer therapy
#3981Composition and method for inner ear sensory hair cell regeneration and replacement
#3982Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1
#3983GENE THERAPY FOR DIABETES WITH CHITOSAN-DELIVERED PLASMID ENCODING GLUCAGON-LIKE PEPTIDE 1
#3984Methods and compositions for malic enzyme 2 (ME2) as a target for cancer therapy
#3985GENE DEFECTS AND MUTANT ALK KINASE IN HUMAN SOLID TUMORS
#3986Methods and compositions for the treatment of insulin-associated medical conditions
#3987Methods and compositions for inhibition of axonal degeneration by modulation of the DLK/JNK pathway
#3988Inhibitory RNAs to RNA binding proteins hnRNPA1, hnRNPA2 and PTB and uses thereof
#3989Targeted particles comprising landscape phage fusion proteins and heterologous nucleic acid
#3990Compositions and methods for treating bone conditions
#3991Methods for modulating skeletal remodeling and patterning by modulating SHN2 activity, SHN3 activity, or SHN2 and SHN3 activity in combination
#3992NOVEL BIOMARKERS AND TARGETS FOR OVARIAN CARCINOMA
#3993Promoting Erythropoietin, Erythrocyte, and Hematopoietic Stem Cell Production By Activating HIF In OsteoBlasts
#3994MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE
#3995COMPOSITIONS AND METHODS FOR THE TREATMENT OF A NEOPLASIA
#3996Detection and treatment of autoimmune disorders
#3997Micro-RNA family that modulates fibrosis and uses thereof
#3998MCPIP PROTECTION AGAINST OSTEOCLAST PRODUCTION
#3999Anti-human CCR7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier
#4000Methods of altering bone growth by administration of sost or wise antagonist or agonist
#4001CNS targeting AAV vectors and methods of use thereof
#4002METHODS AND COMPOSITIONS FOR IMPROVING SLEEP AND MEMORY
#4003Self-assembed conjugate and use thereof
#4004Method for producing novel hiPSC by means of miRNA introduction
#4005Methods and Compositions Related to DLK-1 and the P38 MAPK Pathway in Nerve Regeneration
#4006Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals
#4007METHOD FOR PREDICTING THE RESPONSIVENESS TO CHEMOTHERAPY
#4008COMPOSITIONS AND METHODS FOR INHIBITION OF OR TREATMENT OF DENGUE VIRUS INFECTION
#4009Method for producing novel hipsc by means of siRNA introduction
#4010COMPOSITIONS AND METHODS FOR INDUCING CANCER CELL DEATH
#4011Compositions and methods for inhibiting expression of mutant EGFR gene
#4012Dual targeting siRNA agents
#4013TREATMENT OF ABNORMAL OR EXCESSIVE SCARS
#4014Methods and compositions for cell-proliferation-related disorders
#4015Nucleic acid having adjuvanticity and use thereof
#4016Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
#4017MIRNA EXPRESSION IN ALLERGIC DISEASE
#4018Compositions and methods for silencing SMAD4
#4019Composition for regenerating normal tissue from fibrotic tissue
#4020Selective inhibition of polyglutamine protein expression
#4021Method for selective oligonucleotide modification
#4022Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences
#4023DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSIS
#4024Method for ProNGF assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of ProNGF
#4025Prostaglandin transporter inhibitors
#4026Inhibition of LAR Phosphatase to Enhance Therapeutic Angiogenesis
#4027TREATMENT OF ABNORMALITIES OF GLUCOSE METABOLISM WITH AN ANTAGONIST OF INHIBITOR OF DIFFERENTIATION 1
#4028NCAM-VASE AND NEURODEGENERATION
#4029RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)
#4030Methods and compositions for prevention or treatment of RSV infection
#4031Method and medicament for inhibiting the expression of a given gene
#4032Method of treating inflammatory bowel disease
#4033Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells
#4034Regulators of NFAT and/or store-operated calcium entry
#4035INTRACELLULAR DNA RECEPTOR
#4036METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF
#4037NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES
#4038Compositions and methods for treating cancer and modulating stress granule formation
#4039Asymmetric liposomes for the highly efficient encapsulation of nucleic acids and hydrophilic anionic compounds, and method for preparing same
#4040Anticancer composition
#4041Compositions and methods for the treatment of tumor of hematopoietic origin
#4042Methods and compositions for treating prostate cancer
#4043METHOD OF TREATING TUMOR RESISTANT TO HERCEPTIN OR PACLITAXEL USING FOXM1 INHIBITORS AND DETECTING SAME
#4044LONG NON-CODING RNA SPRY4-IT1 AS A DIAGNOSTIC AND THERAPEUTIC AGENT
#4045Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA
#4046RNA interference in ocular indications
#4047ROR1 AS A GENE TARGET IN ACUTE LYMPHOBLASTIC LEUKEMIA
#4048Method for inhibiting the induction of cell death by inhibiting the synthesis or secretion of age-albumin in cells of the mononuclear phagocyte system
#4049Method for inhibiting HIV replication in mammal and human cells
#4050Modulation of BCL11A for treatment of hemoglobinopathies
#4051Compositions and methods for silencing apolipoprotein B
#4052Dual Targeted siRNA Therapeutics for Treatment of Diabetic Retinopathy and Other Ocular Neovascularization Diseases
#4053Methods and compositions for treating cancer
#4054Cyclic cationic lipids and methods of use
#4055PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CHLAMYDIAL INFECTION
#4056Methods for treating hepatocellular carcinoma
#4057Method of producing lipid nanoparticles for drug delivery
#4058METHODS OF LIMITING MICROVASCULAR DAMAGE FOLLOWING ACUTE MYOCARDIAL ISCHEMIA
#4059METHOD FOR THE DELIVERY OF OLIGONUCLEOTIDES
#4060Uniform field magnetization and targeting of therapeutic formulations
#4061Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression
#4062Methods of using SCD1 antagonists
#4063Composition for nucleic acid delivery using metal nanoparticles and preparing method thereof
#4064Compositions and Methods for Reduced Scarring and for Treatment of Fibrosis
#4065Therapeutic uses of inhibitors of RTP801
#4066Hyaluronic acid decomposition-promoting factor and inhibitor thereof
#4067Agent for suppressing expression of dominant allele
#4068Apoptosis inducer for cancer cell
#4069MicroRNA-130a,b as a tumor suppressor and sensitizing agent for chemotherapy
#4070TREATING CANCER BY MODULATING MAMMALIAN STERILE 20-LIKE KINASE 3
#4071Methods and compositions for reducing interleukin-4 or interleukin-13 signaling
#4072siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions
#4073USP47 inhibitors and methods to induce apoptosis
#4074CANCER-SPECIFIC GENETIC REARRANGEMENTS
#4075MICROBUBBLE COMPLEXES AND METHODS OF USE
#4076Treatment of methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA
#4077RNA interference of galectin-3 expression and methods of use thereof
#4078Retinoid-liposomes for treating fibrosis
#4079Reverse micelle system comprising nucleic acids and use thereof
#4080Compositions and methods for silencing genes expressed in cancer
#4081Mutator activity induced by microRNA-155 () links inflammation and cancer
#4082Cationic lipids
#4083Cationic lipids and methods of use thereof
#4084SiRNA hydrogel and method for manufacturing the same
#4085Nucleic acid complexes
#4086Treatment of fibrosis using microRNA 19b
#4087Monomers and oligonucleotides comprising cycloaddition adduct(s)
#4088Methods of Inducing Tissue Regeneration
#4089Prognostic Method for Pulmonary Adenocarcinoma, Pulmonary Adenocarcinoma Detection Kit, and Pharmaceutical Composition for Treating Pulmonary Adenocarcinoma
#4090Composite body for antigen or drug delivery
#4091Inhibitors of FAM3B gene, inhibitor compositions, inhibiting methods and applications of inhibitors in preparing pharmaceuticals
#4092Double-stranded oligonucleotides
#4093Single chemical entities and methods for delivery of oligonucleotides
#4094SIRNA-based therapy of Fibrodyplasia Ossificans Progressiva (FOP)
#4095Isoform of bruton's tyrosine kinase (BTK) protein
#4096ISOFORM OF BRUTON'S TYROSINE KINASE (BTK) PROTEIN
#4097NEW ISOFORM OF BRUTON'S TYROSINE KINASE (BTK) PROTEIN
#4098PROMOTION OF WOUND HEALING
#4099Viral Immunogenic Compositions
#4100STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES
#4101Siglec 15 antibodies in treating bone loss-related disease
#4102Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer
#4103Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21
#4104Lipid formulated dsRNA targeting the PCSK9 gene
#4105Oligonucleotide compounds comprising non-nucleotide overhangs
#4106Mitochondrial enhancement of cells
#4107RNAi Modulation Of RSV And Therapeutic Uses Thereof
#4108MODULATION OF TIMP1 AND TIMP2 EXPRESSION
#4109Genetic Inhibition by Double-Stranded RNA
#4110Pharmaceutical composition for treating cancer
#4111Semaphorin 3C (Sema3C) inhibitor therapeutics, methods, and uses
#4112PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11 (PTPN11) AND TUMOR INITIATING CELLS
#4113siRNA for inhibition of c-Met expression and anticancer composition containing the same
#4114Compositions and methods for inhibiting expression of Eg5 and VEGF genes
#4115Fidgetin-like 2 as a target to enhance wound healing
#4116Cationic lipids for therapeutic agent delivery formulations
#4117Compounds for the treatment of autism
#4118iRNA Agents Targeting VEGF
#4119MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
#4120Methods of diagnosing cancer
#4121Method for selectively inhibiting the activity of ACAT1 in the treatment of alzheimer's disease
#4122Compounds for targeting drug delivery and enhancing siRNA activity
#4123Organic compositions to treat Beta-ENaC-related diseases
#4124GNAQ targeted dsRNA compositions and methods for inhibiting expression
#4125Method of treatments related to the gene
#4126Compositions and methods for transport across the blood brain barrier
#4127TARGETED DELIVERY OF siRNA
#4128Antisense antiviral compounds and methods for treating a filovirus infection
#4129Transforming growth factor-beta (TGF-beta) antagonists for use in treating pain
#4130Uniform Field Magnetization and Targeting of Therapeutic Formulations
#4131Compositions and methods for inhibiting gene expression of hepatitis B virus
#4132RNAi modulation of RSV and therapeutic uses thereof
#4133SMOCI, TENASCIN-C AND BRAIN CANCERS
#4134Influenza targets
#4135Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor
#4136THERAPEUTIC AGENT FOR FIBROID LUNG
#4137Modified siRNA molecules and uses thereof
#4138EP1 INHIBITION
#4139Methods for treating and/or limiting development of diabetes
#4140Therapeutic Applications Targeting SARM1
#4141Method for inhibiting angiogenesis
#4142Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
#4143Low density lipoprotein receptor-mediated siRNA delivery
#4144Delivery of dsRNA to arthropods
#4145INHIBITING HEPATITIS C VIRAL REPLICATION WITH SIRNA COMBINATIONS
#4146Biomarker for identifying subgroup of early-stage lung adenocarcinoma patients
#4147CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS
#4148Tetrary gene delivery system for gene therapy and methods of its use
#4149TREATMENT OF FILAGGRIN (FLG) RELATED DISEASES BY MODULATION OF FLG EXPRESSION AND ACTIVITY
#4150Methods of Inducing Tissue Regeneration
#4151Lipids and compositions for intracellular delivery of biologically active compounds
#4152Prostate carcinogenesis predictor
#4153Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR)
#4154NOVEL COCHLEATE FORMULATIONS
#4155MODULATION OF GPCR-MEDIATED CAMP PRODUCTION THROUGH LRP6 AND ITS THERAPEUTIC APPLICATION
#4156Methods for Treating Fatty Liver Disease
#4157Treatment of pulmonary and pleural fibrosis using HSP27 inhibitors
#4158Diagnostic, prognostic and therapeutic uses of long non-coding RNAs for cancer and regenerative medicine
#4159Use of RNA interference for treating or reducing pain
#4160Peptide oligonucleotide conjugates
#4161Synthetic mimics of miR-34
#4162Stabilized STAT3 decoy oligonucleotides and uses therefor
#4163POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER
#4164Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers
#4165HUMAN FERTILITY TEST USING DPY19L2
#4166Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
#4167ACTIVITY GENERATING DELIVERY MOLECULES
#4168Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
#4169Localized Delivery of Gold Nanoparticles for Therapeutic and Diagnostic Applications
#4170Synthetic mimics of MIR-124
#4171USE OF CYTOKINE EXPRESSION TO PREDICT SKIN INFLAMMATION; METHODS OF TREATMENT
#4172MicroRNA-140-5p as a tumor suppressor and sensitizing agent for chemotherapy
#4173SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
#4174MEDICAMENT FOR THE TREATMENT AND PREVENTION OF LIVER FAILURE
#4175Methods and compositions for treating HIV infection
#4176Methods and compositions for eliciting an immune response against hepatitis B virus
#4177MULTIPLEX DICER SUBSTRATE RNA INTERFERENCE MOLECULES HAVING JOINING SEQUENCES
#4178ANTI-CXCL9, ANTI-CXCL10, ANTI-CXCL11, ANTI-CXCL13, ANTI-CXCR3 AND ANTI-CXCR5 AGENTS FOR INHIBITION OF INFLAMMATION
#4179Compositions for controlling mites in bees
#4180Methods and compositions for modulation of histone ubiquitination
#4181Method for inducing cancer cell apoptosis or inhibiting the cancer cell migration
#4182Therapeutic agent for tumor
#4183Methods and compositions for treating diseases, disorders or injury of the CNS
#4184Methods for delivery of siRNA to the spinal cord and therapies arising therefrom
#4185Means and methods for the treatment of hearing loss and phantom hearing
#4186Composition for treatment of pancreatic cancer
#4187MicroRNA-29a,b,c as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
#4188RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis
#4189Methods and kits to identify invasive glioblastoma
#4190PHARMACEUTICAL COMPOSITION CONTAINING MEDICAMENT-CONTAINING FINE PARTICLES AND METHOD FOR PRODUCING SAME
#4191Targeted Nanocarrier Systems for Delivery of Actives Across Biological Membranes
#4192Compositions and methods for modulating circadian synchronization
#4193Enhancement of placental stem cell potency using modulatory RNA molecules
#4194Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
#4195Compositions and methods for inhibiting expression of transthyretin
#4196Single monomer derived linear-like copolymer comprising polyethylenimine and poly(ethylene glycol) for nucleic acid delivery
#4197Methods and compositions for modulating tau levels
#4198CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS
#4199Topical vaccination via DNA microparticles
#4200Methods and compositions for improved deliver, expression or activity of RNA interference agents